Reach Us +44-7482-877761
Editor - Rao L. Divi | National Cancer Institute | 16568
ISSN: 2329-9126

Journal of General Practice
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Rao L. Divi

Rao L. Divi
Rao L. Divi
Program Director
Methods and Technologies Branch
Division of Cancer Control and Population Sciences
National Cancer Institute, NIH
Bethesda, USA


Rao L. Divi is a Program Director in the Methods and Technologies Branch of Epidemiology and Genomics Research Program in Division of Cancer Control and Population Sciences (DCCPS) at National Cancer Institute (NCI), NIH. He received his doctorate in Biochemistry from Osmania University, India in 1993 and was a postdoctoral fellow at National Center for Toxicological Research from 1993-1996. He studied “Antithyroid Mechanisms of Natural Compounds and Drugs.” In 1997, Dr. Divi joined the Carcinogen-DNA Interactions section, Laboratory of Cancer Biology and Genetics, NCI where his research interests continued in “Mitochnodrial Toxicity of Antiretroviral Drugs” and “Molecular Mechanisms of Carcinogenesis.” Dr. Divi is author/co-author on more than 50 publications including peer-reviewed articles and/or book chapters, etc., and is currently a member on the NCI Special Studies Institutional Review Board, committee member (ad hoc) of FASEB’s Breakthroughs in Bioscience, International Lymphoma Epidemiology Consortium, and International Multiple Myeloma Consortium. He is the DCCPS’ representative for NCI’s Innovative Molecular Analysis Technologies Development Program. His goal is to empower future generation.

Research Interest

Methods and technologies for molecular epidemiology in cancer; Carcinogenesis; Advanced cancer detection and diagnostic technologies for cancer prevention and control